Normal Boiling Points for Organic Compounds: Correlation and Prediction by a Quantitative Structure−Property Relationship-Reference-Cited by-同舟云学术

Normal Boiling Points for Organic Compounds: Correlation and Prediction by a Quantitative Structure−Property Relationship

Published:1998-01-19 Issue:1 Volume:38 Page:28-41
ISSN:0095-2338
Container-title:Journal of Chemical Information and Computer Sciences
language:en
Short-container-title:J. Chem. Inf. Comput. Sci.

Author:

Katritzky Alan R.¹,Lobanov Victor S.¹,Karelson Mati¹

Affiliation:

1. Center for Heterocyclic Compounds, Department of Chemistry, University of Florida, P.O. Box 117200, Gainesville, Florida 32611-7200, 3-Dimensional Pharmaceuticals, Inc., 665 Stockton Drive, Suite 104, Exton, Pennsylvania 19341, and Department of Chemistry, University of Tartu, 2 Jakobi Street, Tartu EE 2400, Estonia

Publisher

American Chemical Society (ACS)

Subject

Computational Theory and Mathematics,Computer Science Applications,Information Systems,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ci970029v

Reference34 articles.

1. Correlation of Boiling Points with Molecular Structure. 1. A Training Set of 298 Diverse Organics and a Test Set of 9 Simple Inorganics

2. Note: Correlation of flash points

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel selection of recycled PET surrogates based on non-targeted screening of non-intentionally added substances and chemometrics;Microchemical Journal;2024-11

2. QSPR analysis of drugs used for treatment of hepatitis via reduced reverse degree-based topological descriptors;Physica Scripta;2024-09-06

3. Efficient Fabrication of Plasmonic Nanostructures Using Chloroform‐Mediated Heterogeneous Bonding;Advanced Functional Materials;2024-06-27

4. Designing green chemicals by predicting vaporization properties using explainable graph attention networks;Green Chemistry;2024

5. Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform;The Oncologist;2023-03-20